The Effect of Combined Treatment With Sodium Phenylbutyrate and Cisplatin, Erlotinib, or Gefitinib on Resistant NSCLC Cells
Clinical Pharmacology: Advances and Applications - New Zealand
doi 10.2147/cpaa.s174074
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2018
Authors
Publisher
Informa UK Limited